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CXCR4 is a coreceptor of HIV-1 infection in host
cells. Through a photocrosslinking study to identify
receptors involved in internalization of oligoarginine
cell-penetrating peptides (CPPs), we found that
CXCR4 serves as a receptor that stimulatesmacropi-
nocytic uptake of the arginine 12-mer peptide (R12)
but not of the 8-mer. We also found that stimulating
CXCR4 with its intrinsic ligands, stromal cell-derived
factor 1a and HIV-1 envelope glycoprotein 120, in-
duced macropinocytosis. R12 had activity to prevent
viral infection for HIV-1IIIB, a subtype of HIV-1 that
uses CXCR4 as a coreceptor for entry into sus-
ceptible cells, whereas the addition of a macropino-
cytosis inhibitor, dimethylamiloride, resulted in
enhancement of viral infection. The present study
shows that CXCR4 triggers macropinocytosis, which
may have implications for the cellular uptake of
oligoarginine CPPs and internalization of HIV.
INTRODUCTION
Recently developed intracellular delivery technology using cell-
penetrating peptides (CPPs) has provided novel strategies for
drug delivery, diagnostics, and chemical biology (Futaki, 2006;
Wender et al., 2008). Conjugation of CPPs to molecules of
interest leads to the efficient delivery of these molecules into
cells, and successful modulation of cellular function has been
reported. Arginine-rich CPPs, including oligoarginines and one
derived from positions 48–60 of HIV-1 Tat protein (Tat peptide),
are a representative CPP class (Futaki, 2006). Understanding
the internalization methods of these CPPs and their conjugates
should be beneficial for the design of more sophisticated andChemistry & Biology 19, 1437–144effective delivery systems. However, there remainmany ambigu-
ities regarding their methods of internalization.
It has been demonstrated by our group and others that macro-
pinocytosis also plays an important part in the cellular uptake of
arginine-rich CPPs to achieve high-efficiency intracellular
delivery (Nakase et al., 2004; Wadia et al., 2004). Macropinocy-
tosis is a transient, actin-driven fluid-phase endocytosis that
involves membrane ruffling and the formation of large vacuoles
called macropinosomes (Swanson and Watts, 1995; Conner
and Schmid, 2003; Falcone et al., 2006). In most cells other
than dendritic cells, macropinocytosis is not a constitutive endo-
cytosis process but rather is activated by external stimuli such as
epidermal growth factors and fibroblast growth factor 2 (FGF2)
(Tkachenko et al., 2004). Ruffling of plasma membranes is
induced by actin reorganization (Meier et al., 2002). Protrusion
of the plasma membranes, followed by membrane fusion, leads
to the formation of large endocytic vacuoles with a diameter that
often exceeds 1 mm (Conner and Schmid, 2003). The importance
of this endocytic pathway to the infection of various viruses has
recently received attention (Mercer and Helenius, 2008, 2009).
On the other hand, CXCR4 is a CXC chemokine receptor (C-X-
C chemokine receptor type 4) and is also a coreceptor for HIV-1
infection. Binding of HIV-1 envelope glycoprotein 120 (gp120) to
CD4 host cells leads to further interactions with CXCR4 and the
eventual fusion of viral and host cell membranes driven by the
HIV-1 gp41 protein (Tamamura et al., 2005). CXCR4 is thus a
promising target for anti-HIV agents (Schramm et al., 2000).
Stromal cell-derived factor 1a (SDF-1a) is a natural CXCR4
ligand. Induction of CXCR4 endocytosis and actin polymeriza-
tion by SDF-1a has been suggested (Rey et al., 2007; Yoder
et al., 2008). It has been reported that SDF-1a induces rapid
endocytosis and downmodulation of CXCR4 (Signoret et al.,
1997; Orsini et al., 1999; Venkatesan et al., 2003). It has also
been reported that treatment of cells with SDF-1a leads to actin
polymerization (Rey et al., 2007; Yoder et al., 2008). However,
although involvement of clathrin-dependent endocytosis has6, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1437
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Figure 1. Identification of CXCR4 as a Potential Receptor that Contributes to Cellular Uptake of the Arginine R12 Peptide
(A) Outline of the photocrosslinking study to identify the cell-surface receptor for the R12 peptide.
(B) Structure of biotin-TmdPhe-R12, the photocrosslinking probe to identify the receptor responsible for R12 cellular uptake. Structures of other peptides used in
this study are given in Figure S3.
(C) SDS-PAGE of the proteins obtained with magnetic spheres after photocrosslinking of HeLa cells with biotin-TmdPhe-R12 (0.5 mM) or biotin-TmdPhe-R4
(1.5 mM) for 3 min at 4C. Arrows indicate specific bands observed for biotin-TmdPhe-R12-treated cells.
(D) Western blot analysis of the proteins obtained with magnetic spheres from biotin-TmdPhe-R12-treated cells yielded positive staining with the anti-CXCR4
antibody but not with the anti-CD71 antibody.
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cating that SDF-1a induces macropinocytosis.
In this report, we synthesized dodeca-arginine (R12) bearing
the phenyltrifluoromethyldiazirine moiety as a photocrosslinker
with the hope of identifying the receptors responsible for the
cellular uptake of oligoarginines (Figure 1A). We found that
CXCR4 is a receptor that stimulates cellular uptake of the R12
peptide. Binding of R12 to CXCR4 stimulates actin organization
and macropinocytosis. The binding of R12 to CXCR4 also leads
to CXCR4 internalization. We also found that stimulating CXCR4
with its natural ligands, SDF-1a or gp120, triggered macropino-
cytosis together with internalization of the receptor. These
results thus shed light on the roles of CXCR4 as a receptor for
stimulating cellular uptake of arginine-rich CPPs and the induc-
tion of macropinocytosis, whichmay have implications in cellular
responses, accompanied by intracellular delivery using oligoar-
ginines, and in HIV infection.
RESULTS
CXCR4 as a Potential Target of R12 on Plasma
Membranes
Photocrosslinking is a powerful methodology to detect
molecular interactions in cells (Tomohiro et al., 2005). A biotin-
tagged R12 peptide bearing trifluoromethyldiazirinephenylala-
nine (biotin-TmdPhe-R12) was designed to identify cell-surface
molecules that can be recognized by theR12peptide (Figure 1B).
The R12 peptide was selected as a typical arginine-rich CPPwith
superior internalization efficiency, compared with the R8 and Tat
peptides (Kosuge et al., 2008). Aryl-3-phenyl-3-trifluoromethyl-
diazirine derivatives are effective photocrosslinking agents and
are readily incorporated into peptide chains using trifluorome-
thyldiazirinephenylalanine derivatives developed by Hatanaka
and coworkers (Nakashima et al., 2006). The biotin tag was
incorporated at the N terminus of the peptide together with a
flexible linker (g-aminobutyric acid) to facilitate the isolation of
crosslinked proteins with the TmdPhe-R12 peptide. The biotin-
TmdPhe-R12 peptide was thus prepared by Fmoc solid-phase
peptide synthesis without difficulty.
HeLa cells pretreated with 0.5 mMbiotin-TmdPhe-R12 at 37C
for 30 swere irradiatedwith UV light (365 nm) at 4C for 3min and
washed with PBS prior to cell lysis. The peptide concentration
and incubation time were set so that the peptide interacted
with cell-surface molecules, but no significant endocytosed
peptide signal was observed after examining the time course
and the FITC-TmdPhe-R12 internalization methods (see Fig-(E and F) Downregulation of CXCR4 led to diminished cellular uptake of R12-Alex
flow cytometry (F). Scale bars represent 50 mm. Peptide concentration, 10 mM. Da
different days. Asterisks indicate statistically significant differences compared to
(G) Treating the cells with a CXCR4-specific antagonist, FC131, also inhibited the c
and 20 mg/ml, respectively. Data are shown as the mean ± SD of three indepen
significant differences compared to the negative-control cells. ****p < 0.0001 (tw
(H) Live cell analysis of the colocalization of R12-Alexa568 with CXCR4-Venus on
and the surfaces of live cells facing the bottom glass were observed by confoca
(I) Treatment with the Gi signaling-pathway inhibitor PTX (100 ng/ml) yielded de
transferrin concentrations were 10 mM and 50 mg/ml, respectively. Data are sh
experiments performed on different days. Asterisks indicate statistically signific
followed by Bonferroni’s post hoc test).
See also Figure S1.
Chemistry & Biology 19, 1437–144ure S1A available online). The biotin-TmdPhe-R4 peptide was
used as a negative control; the R4 peptide showed no signifi-
cant internalization (Futaki et al., 2001; Kosuge et al., 2008).
After dialysis at 4C for 12 hr, the samples were treated with
streptavidin magnetic spheres for 1 hr. Proteins crosslinked
with the R12 peptide were collected and the samples were sub-
jected to SDS-PAGE (Figure 1C). Proteins corresponding to four
major bands >240 kDa were specifically observed from cells
treated with biotin-TmdPhe-R12 (arrows in Figure 1C) com-
pared with those treated with biotin-TmdPhe-R4, and were
digested with trypsin. The digested peptides were analyzed by
MALDI-TOF mass spectrometry (MS) with peptide mass finger-
printing (PMF), and it was determined that the four bands were
derived from myosin-9 (nonmuscle myosin heavy chain IIA).
Involvement of myosin-9 in the endocytosis of CXCR4 and
their colocalization on the cell surface, together with cell-
surface exposure of myosin-9, has been suggested previously
(Rey et al., 2007; Arii et al., 2010). Additionally, CXCR4 is
expressed on the cell surface in a complex with syndecan-4
(Hamon et al., 2004). A western blot analysis of the proteins
obtained using magnetic spheres from biotin-TmdPhe-R12-
treated cells yielded positive staining with an anti-CXCR4 anti-
body, whereas no significant staining was observed for samples
from biotin-TmdPhe-R4-treated cells (Figure 1D). Similarly,
positive staining with anti-syndecan-4 antibody was observed
for samples obtained from biotin-TmdPhe-R12-treated cells,
which was almost twice as strong as that from biotin-
TmdPhe-R4-treated cells (Figure 1D). These results suggest
the possibility that CXCR4 plays a role in the cell-surface recog-
nition of biotin-TmdPhe-R12.
CXCR4 as a Receptor to Promote R12 Uptake
The involvement of CXCR4 in the cellular uptake of R12 was then
confirmed using CXCR4-knockdown HeLa cells, expressing
48% decreased levels of the receptor (Figure S1B). A significant
decrease in R12-Alexa fluorescence signals was observed in the
CXCR4-knockdown cells (Figure 1E, right) versus that in non-
treated cells (Figure 1E, left) or in cells treated with negative-
control siRNA (Figure 1E, middle). Fluorescence-activated cell
sorting analysis showed a considerable decrease (32%) in the
cellular uptake of the R12 peptide by CXCR4 knockdown under
the same conditions (Figure 1F). Treating HeLa cells with the
CXCR4-specific antagonist FC131 (cyclo[-D-Tyr-Arg-Arg-Nal-
Gly-]) (Fujii et al., 2003) (10 mM) also resulted in a decrease in
R12 peptide cellular uptake (Figure 1G). These results suggest
the involvement of CXCR4 in the cellular uptake of R12.a, analyzed by confocal laser scanning microscopy without fixation (E) and by
ta are shown as themean ± SD of three independent experiments performed on
the negative-control cells. ****p < 0.0001 (unpaired Student’s t test).
ellular uptake of R12-Alexa. Peptide and transferrin concentrationswere 10 mM
dent experiments performed on different days. Asterisks indicate statistically
o-way ANOVA followed by Bonferroni’s post hoc test).
the cell surface. Cells were treated with 5 mM R12-Alexa568 for 10 min at 4C
l laser scanning microscopy. Scale bars represent 5 mm.
creased cellular uptake of R12-Alexa but not R8- or Tat-Alexa. Peptide and
own as the mean ± SD of three or four values obtained from independent
ant differences from the no-inhibitor groups. ****p < 0.0001 (two-way ANOVA
6, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1439
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Figure 2. Internalization of CXCR4 by Treatment with R12
(A) Specific labeling of E3-tagged CXCR4 on cell surfaces using fluorescently labeled K4 probe.
(B) Internalization of CXCR4 following R12 treatment. CHO cells expressing E3-CXCR4were treated with nonlabeled R12 (10 mM) for 30min, and then the amount
of the CXCR4 remaining on the cell surface was analyzed by treatment with E3-specific fluorescein-labeled K4 peptide (FL-K4). Data are shown as themean ± SD
of three independent experiments. Asterisks indicate statistically significant differences from control cells. **p < 0.01 (unpaired Student’s t test).
(C) Colocalization of R12 with CXCR4 after cell treatment with 5 mMR12-Alexa568 for 30 min at 37C. The live cells were then analyzed directly by confocal laser
scanning microscopy without fixation. Scale bars represent 5 mm.
(D) CXCR4 internalizes into cells with the macropinocytosis marker dextran-TMR (70 kDa). CHO-C4V cells were treated with 10 mMnonlabeled R12 together with
dextran-TMR (1mg/ml) and observed by time-lapse imaging. Significant colocalization of the CXCR4-Venus and dextran-TMR signals was observed, suggesting
that they were captured in the same endosomal vesicles. Yellow arrows indicate that the vesicles contain both CXCR4-Venus and dextran-TMR. The scale bar
represents 5 mm.
See also Figure S2.
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CXCR4 Stimulates MacropinocytosisInterestingly, no significant reduction in R8 or Tat (10 mM)
cellular uptake was observed in CXCR4-knockdown cells (Fig-
ure 1F), and similar patterns were observed in FC131-treated
cells (Figure 1G). Thus, CXCR4 was not responsible for the
cellular uptake of these peptides. The R8 and Tat peptides are
typical arginine-rich CPPs with a smaller number of arginines in
their sequences than R12 (Futaki, 2006; Kosuge et al., 2008),
suggesting diversity in cellular uptake mechanisms even among
arginine-rich peptides.
Cell-surface interaction of CXCR4 with R12 was confirmed by
confocal laser scanning microscopy (Figure 1H). We established
CHO cells stably expressing CXCR4 (CHO-C4V) in which a fluo-
rescent protein, Venus, was tagged to the CXCR4 C terminus
(cytoplasmic side). Cells were treated with Alexa 568-labeled
R12 peptide (R12-Alexa568) at 4C for 10 min, conditions under
which endocytosis does not occur. Significant colocalization of
the CXCR4 signals with R12 (Figure 1H) suggested specific
binding of R12 to CXCR4 on the cell surface, whereas lower
levels of colocalized signals were observed when the cells
were treated with Alexa 568-labeled R8 and Tat peptides
(Figure S1C).
Binding of CXCR4 to its natural ligand, SDF-1a, leads to actin
reorganization via the Gi protein-signaling pathway (Mo¨hle et al.,
2001). Indeed, a marked lamellipodia (i.e., thin, veil-like exten-
sions at the edge of cells that contain a dynamic array of actin1440 Chemistry & Biology 19, 1437–1446, November 21, 2012 ª2012filaments, typically observed for cells treated with oligoarginine
CPPs) formation was observed for control cells by treatment
with R12 for 20 min; however, no significant alteration in actin
structurewasobserved inCXCR4-knockdowncells (FigureS1D).
Cellular uptake of R12-Alexa was suppressed by 30% in the
presence of pertussis toxin (PTX), an inhibitor of the Gi protein-
signaling pathway (Phillips and Ager, 2002) (Figure 1I). Further-
more, PTX treatment also led to a significant suppression in
the formation of lamellipodia by the R12 peptide (data not
shown). These results suggest that CXCR4 serves as an R12
receptor to promote actin organization, together with uptake of
the R12 peptide. Involvement of the Gi protein-signaling
pathway was suggested in the above process. Here again,
cellular uptake of R8 and the Tat peptide was not affected by
PTX treatment (Figure 1I).
Treating cells with the R12 peptide led to internalization of the
CXCR4 receptor. A coiled-coil tag/probe system, developed by
Yano et al. (2008), was used to analyze this result. Specifically,
CXCR4 bearing a surface-exposed tag sequence E3 (EIAALEK)3
at the N terminus (E3-CXCR4) was expressed on CHO-K1 cells
(Figure 2A). After treating the cells with R12 or other CXCR4
ligands, E3-CXCR4 remaining on the plasma membranes was
quantified by a fluorescently labeled E3-specific peptide probe,
K4 (KIAALKE)4. This system was expected to more accurately
assess the quantities of cell surface-exposed receptors,Elsevier Ltd All rights reserved
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antibodies; binding of receptor-specific antibodies may be
hampered when their ligands are tightly bound to the receptor.
However, the relatively small K4 probe used in this system al-
lowed us to detect CXCR4 without disruption by ligand binding
(Yano et al., 2008). Treating the cells with R12 peptide for
30 min resulted in the internalization of cell-surface CXCR4; an
30% decrease in the amount of CXCR4 on cell surfaces was
observed following this treatment compared with nontreated
cells (Figure 2B).
The intracellular fate of CXCR4 after bindingwith R12was then
analyzed using theCXCR4-Venus systememployed in Figure 1H,
but this time cells were incubated at 37C to allow endocytic
cellular uptake. Treatment of the cells with R12-Alexa for
30 min led to internalization of CXCR4 and significant colocaliza-
tion of the R12-Alexa568 signal with CXCR4 in the cytoplasm
(Figure 2C). On the other hand, large amounts of CXCR4 re-
mained on the cell surface, even after treatment with R8- and
Tat-Alexa568, which yielded considerably fewer colocalized
signals in the cytoplasm compared to R12 treatment (Fig-
ure S2A). Time-lapse imaging of CXCR4-Venus cells treated
with a macropinosome marker (70 kDa dextran labeled with tet-
ramethylrhodamine; dextran-TMR) in the presence of R12
peptide showed significant colocalization of the signals of Venus
and TMR, indicative of CXCR4 internalization via the macropino-
cytic pathways stimulated by the R12 peptide (Figure 2D).
Because endosomes formed by macropinocytosis (i.e., macro-
pinosomes) can be CXCR4-Venus signals colocalizing with
dextran-TMR, compared with those without significant colocali-
zation (see Figure S2B), this also suggests that these signals
represent macropinosomes. Thus, CXCR4 serves as a receptor
of R12 and is internalized into cells via macropinocytosis
together with R12.
Note that the above observation would not necessarily indi-
cate CXCR4-mediated macropinocytosis as the sole and exclu-
sive pathway for R12 uptake. R8 and other arginine-rich peptides
also employ macropinocytosis for their cellular uptake (Nakase
et al., 2004); as shown in this study, themethods are not identical
to that using CXCR4. However, it could be possible that a part of
R12 may also be internalized in the cells using similar methods
employed by R8. Dynasore is an inhibitor of dynamin that is crit-
ically involved in clathrin- or caveolae-mediated endocytosis.
Treating the cells with dynasore yielded an 35% decrease in
5 mM R12 uptake (Figure S2C). This result suggests the possi-
bility that certain dynamin-dependent endocytic pathways may
be involved in the cellular uptake of R12 simultaneously with
macropinocytosis. Additionally, only an 10% reduction in the
cellular uptake of R8 was observed under the same dynasore
treatment (Figure S2C). The relative insensitivity of R8 uptake
by dynasore may again suggest differences in the methods of
cellular uptake between R12 and R8.
Stimulation of CXCR4 by SDF-1a or HIV-1 gp120 Also
Leads to Macropinocytosis
If stimulating CXCR4 with R12 induces actin organization and its
macropinocytic uptake, it is possible that stimulating the
receptor with other ligands may also stimulate macropinocyto-
sis. SDF-1a is a typical CXCR4 ligand, and the involvement of
actin reorganization through CXCR4 activation has been re-Chemistry & Biology 19, 1437–144ported (Voermans et al., 2001; Wu and Yoder, 2009). It has
been reported that ligand binding to CXCR4 leads to its internal-
ization via clathrin-dependent endocytosis (Signoret et al., 1997;
Orsini et al., 1999; Venkatesan et al., 2003). However, there is no
report of the relevance of actin reorganization through CXCR4
activation to macropinocytosis induction. In this context, we
examined whether stimulation of CXCR4 with SDF-1a may
lead to macropinocytosis in addition to actin organization and
an eventual increase in its cellular uptake.
Treating HeLa cells with SDF-1a led to an increase in cellular
uptake of 70 kDa dextran of 110%, and the increase in
70 kDa dextran uptake by SDF-1a stimulation was inhibited by
40% in the presence of ethylisopropylamiloride (EIPA), a typical
macropinocytosis inhibitor (Nakase et al., 2004) (Figure 3A).
SDF-1a also induces actin organization, and significant lamelli-
podia formation was also observed for SDF-1a-treated cells
(Figure 3B). These observations suggest the induction of macro-
pinocytosis following CXCR4 stimulation with its natural ligand
SDF-1a. Quantifying the cell-surface receptor using E3-tagged
CXCR4, as used in Figure 2B, showed that stimulating CXCR4
with SDF-1a led to a decrease in cell surface-expressed
CXCR4 by 65% (Figure 3C). A confocal microscopic analysis
showed that CXCR4 tagged with Venus was internalized into
the cells following treatment with SDF-1a (Figure 3D). Colocali-
zation of the CXCR4-Venus signals with those of 70 kDa dextran
suggests the localization of CXCR4 in macropinosomes. To the
best of our knowledge, this is the first demonstration that stimu-
lating CXCR4 with SDF-1a leads to macropinocytosis and the
eventual internalization of CXCR4.
Considerable research has focused on macropinocytosis and
its relevance to viral infections (Mercer and Helenius, 2009). We
not only identified CXCR4 as a receptor that inducesmacropino-
cytosis but also showed that the receptor is internalized in cells
and is trapped inmacropinosomes bound to its ligand. HIV infec-
tion of target cells is accomplished on the cell surface, and
CXCR4 serves as a CD4 protein coreceptor to stimulate viral
binding and successive fusion to the plasma membranes, allow-
ing entry of the viral nucleocapsid. Thus, if HIV binding to CXCR4
induces macropinocytosis, HIV may become trapped in macro-
pinosomes and delivered to cells.
HIV-1 gp120 is a glycoprotein present on the surface of the
viral envelope and is essential for CXCR4 binding, leading to
virus entry into cells (Tamamura et al., 2005). Treatment of
HeLa cells with 500 nM gp120 induced a 25% increase in
70 kDa dextran uptake in 60 min (Figure 3E). Significant lamelli-
podia formation was also observed 20 min after administering
gp120 (Figure 3B). These results suggest that macropinocytosis
may accompany HIV entry into cells (Wu and Yoder, 2009).
Effect of R12 Treatment and Macropinocytosis on HIV
Infection of Host Cells
HIV-1IIIB is a subtype of HIV-1 that uses CXCR4 as a coreceptor
for entry into susceptible cells. Anti-HIV infection activity of R12
for HIV-1IIIB was analyzed using a T cell line,MT-4, which is highly
susceptible to HIV infection (Koyanagi et al., 1985). The cells
were incubated with HIV-1IIIB in the presence of R12 or R8 for
5 days and cell viability was analyzed using the MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay
as reported previously (Kodama et al., 2001), yielding a 50%6, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1441
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Figure 3. Stimulating CXCR4 with SDF-1a and gp120 Induces Actin
Organization and Macropinocytosis
(A) Increase in 70 kDa dextran-fluorescein uptake in HeLa cells following
treatment with 100 nM SDF-1a for 1 hr. Pretreatment with EIPA (100 mM)
diminished the dextran uptake. Data are shown as the mean ± SD of three
independent experiments. Asterisks indicate statistically significant differ-
ences from control cells. ****p < 0.0001 (two-way ANOVA followed by Bon-
ferroni’s post hoc test).
(B) Actin cytoskeleton rearrangement by SDF-1a and gp120. HeLa cells were
treatedwith SDF-1a (100 nM), gp120 (500 nM), and R12 (10 mM) for 20min. The
cells were fixed with 4% paraformaldehyde, and cellular F-actin was stained
with phalloidin-tetramethylrhodamine isothiocyanate. White arrows indicate
lamellipodia. Scale bars represent 10 mm.
(C) Internalization of CXCR4 following treatment with 100 nM SDF-1a (30 min).
The experiments were conducted using E3-CXCR4 cells and FL-K4 as in
Figure 2B. Data are shown as the mean ± SD of three independent experi-
ments. Asterisks indicate statistically significant differences from control cells.
***p < 0.001 (unpaired Student’s t test).
(D) Treating CHO-C4V cells with 100 nM SDF-1a led to the internalization of
CXCR4-Venus by cells. CXCR4-Venus signals showed high colocalizationwith
the macropinosome marker 70 kDa dextran-TMR. Control cells showed less
internalization of CXCR4-Venus and 70 kDa dextran-TMR, yielding little co-
localization with 70 kDa dextran-TMR signals. Scale bars represent 10 mm.
Table 1. Antiviral Activities against HIV-1IIIB Determined by MTT
Assay
Peptide Mean EC50 (nM) ± SD Mean CC50 (nM) ± SD
R12 394 ± 28 >1,000
R8 >1,000 >1,000
Data shown are means and standard deviations obtained from three
independent assays.
Chemistry & Biology
CXCR4 Stimulates Macropinocytosis
1442 Chemistry & Biology 19, 1437–1446, November 21, 2012 ª2012effective concentration (EC50) of 394 ± 28 nM for the R12 peptide
and >1,000 nM for R8 (Table 1). The 50% cytotoxic concentra-
tion (CC50) of both peptides was >1,000 nM. The anti-HIV activity
of R12 for HIV-1IIIB was also confirmed using a single-round
MAGI assay (multinuclear activation of a galactosidase indicator
assay; Kimpton and Emerman, 1992) with an EC50 value of 332 ±
76 nM (AZT reference, 22 ± 2 nM) (Table 2), whereas no inhibitory
effect of R12 (EC50 > 10 mM; AZT reference, 23 ± 8 nM) was
observed for HIV-1BaL infection using CCR5, instead of
CXCR4, as a coreceptor. This suggests that CXCR4 is the target
for R12 inhibition or that the internalization of the receptor results
in HIV entry inhibition.
Macropinocytosis stimulates internalization of CXCR4 as well
as viral uptake into endosomes, whichmay decrease the chance
of HIV entry into host cells via cell-surface fusion (Schaeffer et al.,
2001). The effect of macropinocytosis on HIV entry was also as-
sessed using an HIV-1-based firefly luciferase expression vector
pseudotyped with HIV-1IIIB envelope. MT-4 cells were treated
with dimethylamiloride (DMA), a typical inhibitor of macropinocy-
tosis that has been employed for the analysis of dendritic cell-
mediated HIV-1 endocytosis (Mare´chal et al., 2001), for 30 min
prior to infection and incubated for 48 hr. Treatment of the cells
with DMA resulted in an 30% increase in luciferase activity,
suggesting that inhibition of macropinocytosis improves viral
infection (Figure 3F, left). There was a significant decrease
(70%) in luciferase activity in the presence of R12, confirming
the HIV inhibitory effect of the peptide (Figure 3F, right).
However, this effect was diminished by pretreatment with DMA
(Figure 3F, right).
DISCUSSION
Scientific interest in arginine-rich CPPs has been increasing
due to their ability to bring exogenous molecules into cells. The
ability of arginine-rich CPPs to induce macropinocytosis is
one explanation for their cellular uptake. Although several mem-
brane proteins have previously been considered as potential(E) HIV-1 envelope protein gp120 (500 nM) induces macropinocytosis. HeLa
cells were treated with 500 nM gp120, as shown in (A), for 1 hr. Data are shown
as the mean ± SD of three independent experiments. Asterisks indicate
statistically significant differences from control cells. ****p < 0.0001 (unpaired
Student’s t test).
(F) Inhibition of HIV infection in the presence of a macropinocytosis inhibitor.
MT-4 cells were pretreated with DMA for 30 min at 37C. HIV-based luciferase
expression vector pseudotyped with HIV-1IIIB envelope was used to infect
DMA-treated or untreated cells in the absence or presence of 5 mM R12. After
48 hr of culture, luciferase activity was measured. Data are shown as the
mean ± SD of three independent experiments performed in duplicate. Aster-
isks indicate statistically significant differences from cells treated without
inhibitor. *p < 0.05 (unpaired Student’s t test).
Elsevier Ltd All rights reserved
Table 2. Antiviral Activities Determined by MAGI Assay
Strain
Mean EC50 (nM) ± SD
R12 AZT
HIV-1IIIB 332 ± 76 22 ± 2
HIV-1BaL >10,000 23 ± 8
Data shown are means and standard deviations obtained from three
independent assays. AZT (a nucleoside analog reverse-transcriptase
inhibitor) was used as a control.
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of endocytosis, specifically responsible for the cellular uptake of
arginine-rich CPPs, no substantive receptor has been identified.
It has been reported, for example, that the full-length Tat protein
(86 residues) could activate a vascular endothelial growth factor
receptor (Mitola et al., 1997), but the basic domain (positions 46–
64 of the Tat protein corresponding to the CPP segment) was not
a high-affinity ligand for the receptor (Rubio Demirovic et al.,
2003). It has also been reported that the full-length Tat protein
binds to CXCR4 andworks as an antagonist against the infection
of HIV (Xiao et al., 2000). Interestingly, the basic segment
corresponding to the CPP segment (residues 48–60) was not
responsible for the antagonism activity but rather residues 11–
50 of the Tat protein containing the cysteine-rich domain. There-
fore, it seems likely that the receptors for the full-length Tat
protein may not necessarily work for the receptor of the argi-
nine-rich CPPs. We and others have reported that the interaction
of the arginine-rich peptides with the membrane-associated
proteoglycans, including syndecans, quickly activates the Rac
protein and induces actin organization and macropinocytosis
(Gerbal-Chaloin et al., 2007; Nakase et al., 2007, 2009; Letoha
et al., 2010). Although the interaction of arginine-rich peptides
with membrane-associated proteoglycans may lead to their
multimerization to induce actin polymerization, more evidence
is required to conclude that these proteoglycans are actual
receptors that can induce macropinocytosis; as is seen in the
case of FGF2 (Ishihara, 1993), proteoglycans often couple with
other receptors to activate them. Additionally, it was recently re-
ported that a complex of oligonucleotides with the stearylated
TP-10 analog PepFect14 was taken into cells through scavenger
receptors (Ezzat et al., 2012). This was an important finding that
may potentially be extendable to enhance the biological effects
given by the oligonucleotides. However, recognition of the nega-
tive charges of the complex by the receptor, not of the peptides,
is considered to be the mechanism.
Using synthetic peptides as chemical tools, we have demon-
strated that the CXCR4 chemokine receptor acts as a receptor
to stimulate cellular uptake of the R12 peptide. Cellular uptake
of R12 was inhibited by CXCR4 siRNA knockdown and by
FC131, an antagonist of CXCR4. Treating the cells with R12
led to actin organization (lamellipodia formation) andmacropino-
cytosis, but CXCR4 knockdown effectively prevented the forma-
tion of lamellipodia. Confocal microscopy revealed significant
colocalization of CXCR4 with the R12 peptide on cell surfaces.
Binding of R12 to CXCR4 led to their internalization, and signifi-
cant colocalization of these signals was observed in macropino-
somes in the cells. Treatment of the cells with PTX suppressed
the cellular uptake of R12, suggesting the use of a Gi signaling
pathway for uptake.Chemistry & Biology 19, 1437–144To our knowledge, these results are not only the first report of
a substantive receptor to stimulate the uptake of arginine-rich
CPPs, but are also the first illustration of intracellular traffic of
the receptors involved in R12 uptake after ligand activation.
Interestingly, R8 and Tat, other typical arginine-rich CPPs, did
not significantly activate this CXCR4-mediated uptake path-
way. These peptides are also reported to use macropinocytosis
for their cellular uptake (Nakase et al., 2004, 2007). R12 has
a higher internalization efficiency than the R8 and Tat peptides
(Nakase et al., 2007; Kosuge et al., 2008), and the higher
valency of the guanidino groups in a peptide to ensure greater
interaction with cell-surface molecules has been suggested as
one explanation (Futaki, 2006; Wender et al., 2008). However,
the present study indicates that the lack of CXCR4-mediated
activation of macropinocytosis by R8 and Tat may explain the
higher cellular uptake efficiency of R12 over these peptides.
In addition, if the cooperation of CXCR4 and syndecan-4 is
important for receptor activation, R12 may stabilize these
complex structures.
We also found that stimulation of CXCR4 with an intrinsic
ligand, SDF-1a, induced macropinocytosis. This study also
suggests that macropinocytosis is induced by the interaction
of HIV-1 with CXCR4 on host cell membranes, which leads to
the internalization of the receptor during viral infection of the
host cells. Although the involvement of macropinocytosis with
HIV-1 internalization has been observed in specific cells such
as dendritic cells (Wang et al., 2008), macropinocytosis operates
only for housekeeping in these cells, and there should be distinct
differences in the methods of internalization in the many cells
where macropinocytosis is induced only by external stimuli.
Our study suggests that macropinocytosis stimulates internali-
zation of CXCR4 as well as viral uptake into late endosomes,
which may decrease the chance of HIV entry into host cells via
cell-surface fusion and promote viral degradation in endosomes
(Schaeffer et al., 2001). Thus, macropinocytosis induced by the
interaction with HIV-1 may eventually work as a protective
response by host cells against a viral invasion. In this context,
R12 shows inhibitory activity against HIV-1 infection; interaction
of R12 with CXCR4 leads to internalization of the receptor as well
as viral uptake via macropinocytosis, both of which may inhibit
viral infection. ALX40-4C is an anti-HIV-1 peptide (acetyl-[D-
Arg]9-amide) (Doranz et al., 1997; Zhang et al., 2002), having
structural similarity with R8 and R12. The anti-HIV-1 activity of
ALX40-4C has been claimed to be exclusively by blocking
virus-CXCR4 interactions (Doranz et al., 2001), and this would
also be onemechanism of the anti-HIV-1 activity of R12. Detailed
studies of the effect of ALX40-4C on CXCR4 internalization and
macropinocytosis induction would be beneficial to better under-
stand the contribution of macropinocytosis to the inhibition of
HIV-1 infection.
SIGNIFICANCE
This report has shed light on the roles of CXCR4 as a
receptor for stimulating cellular uptake of arginine-rich
cell-penetrating peptides and the induction ofmacropinocy-
tosis, which should have implications for cellular responses,
accompanied by intracellular delivery using oligoarginines,
and for HIV infection.6, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1443
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Preparation of Biotin-TmdPhe-R12 and Biotin-TmdPhe-R4
H-GABA-TmdPhe-Gly-(Arg[Pbf])12-NH-resin (GABA,g-aminobutyric acid; Pbf,
2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl) was prepared by Fmoc
(9-fluorenylmethyloxycarbonyl) solid-phase peptide synthesis on a Rink amide
resin, as described previously (Kosuge et al., 2008; Nakase et al., 2009), in
which theTmdPhewasassembled into thepeptide chain usingFmoc-TmdPhe,
as is the case with other amino acids. Biotin was then introduced onto the
peptide resin using biotinamidohexanoic acid N-hydroxysuccinimide ester
(Sigma) to yield biotinamidohexanoyl-GABA-TmdPhe-Gly-(Arg[Pbf])12-NH-
resin. The peptide was deprotected and cleaved from the resin by treatment
with a trifluoroacetic acid/ethanedithiol mixture (95:5), followed by reverse-
phase high-performance liquid chromatography purification to yield bio-
tinamidohexanoyl-GABA-TmdPhe-Gly-(Arg)12-amide (biotin-TmdPhe-R12).
The mass of the product was confirmed by MALDI-TOF MS: 2629.99 (calcu-
lated for [M+H]+ 2629.14). Biotin-TmdPhe-R4 was similarly prepared as
biotin-TmdPhe-R12.MALDI-TOFMS:1380.81 (calculated for [M+H]+1379.61).
Photocrosslinking
HeLa cells (1.2 3 106) were plated on 100 mm dishes and cultured in
a-minimum essential medium (a-MEM) containing 10% heat-inactivated
bovine serum (a-MEM/BS) for 48 hr. After the cells were washed three times
with PBS(+), they were treated with biotin-TmdPhe-R12 (0.5 mM) or biotin-
TmdPhe-R4 (1.5 mM) for 30 s at 37C and then irradiated with a UV lamp
with a 365 nm filter for 3 min at 4C. Cells were washed with PBS(+) twice
and lysed in RIPA buffer (100 ml) containing 150 mM NaCl, 10 mM Tris-HCl
(pH 7.2), 0.1% SDS, 1.0%NP-40, 1% deoxycholate, and 5 mMEDTA. Lysates
were then dialyzed against 1,000 ml PBS at 4C for 12 hr using a Slide-A-Lyzer
(molecular weight cutoff 20,000; Pierce).
The protein concentration of the above lysates was adjusted to yield 500 mg
protein/500 ml RIPA buffer, and 10% SDS (214 ml) in water was added to yield
a protein solution containing 3% SDS. Streptavidin magnetic spheres (Prom-
ega; 300 ml) were then added to the solution. After gently mixing at 20C for
1 hr, the streptavidin magnetic spheres, bearing proteins crosslinked with
biotin-TmdPhe-R12, were collected with a magnet and washed with RIPA
buffer, and then the sample buffer for SDS-PAGE (40 ml) containing 3% SDS
and 10% 2-mercaptoethanol was added. After heat denaturation at 85C for
5 min, the mixtures were subjected to electrophoresis. Prior to PMF analysis,
the samples were analyzed by 7.5% SDS-PAGE using silver staining. Protein
bands positive in biotin-TmdPhe-R12-treated cells but negative in biotin-
TmdPhe-R4-treated cells were collected, trypsinized, and subjected to
MALDI-TOF MS/PMF analysis. Western blotting was conducted using 10%
SDS-PAGE prior to sample transfer to PVDF membranes. Anti-CXCR4 anti-
body (1:1,000; ab2074; Abcam), anti-syndecan-4 antibody (1:1,000 dilution;
5G9; Santa Cruz Biotechnology), and anti-CD71 antibody (1:200 dilution;
sc-9099; Santa Cruz Biotechnology), together with the corresponding second
antibody conjugated to horseradish peroxidase, were used to detect the target
proteins.
Confocal Microscopic Observation of CXCR4-Venus and R12-Alexa
CHO-C4V cells (4 3 105 cells/well) stably expressing CXCR4-Venus (see
Supplemental Experimental Procedures) were plated on 35 mm glass-
bottomed dishes and cultured in an F-12 nutrient mixture containing 10%
heat-inactivated fetal bovine serum (F-12/FBS) supplemented with penicillin/
streptomycin and hygromycin for 72 hr. After complete adhesion, the cell-
culture medium was changed to serum-free F-12 and cells were incubated
for 1 hr. The cells were then incubated at 37C in fresh medium (150 ml) con-
taining 5 mM R12-Alexa568. The cells were washed twice with heparin/PBS,
and ice-cold fresh medium without peptides (1 ml) was added. Localization
of R12-Alexa568 and CXCR4-Venus in the cells was then analyzed using an
FV1000 confocal scanning laser microscope (Olympus) equipped with a 603
objective without fixing the cells. Colocalization with dextran-TMR (70 kDa)
was analyzed by incubating CHO-C4V cells with fresh medium containing
10 mM R12 or 100 nM SDF-1a in the presence of 1 mg/ml dextran-TMR for
20 min at 37C.
To observe CXCR4-Venus and R12-Alexa568 on the cell surface, cells were
incubated with serum-free F-12 for 30 min at 4C and treated with 5 mM R12-1444 Chemistry & Biology 19, 1437–1446, November 21, 2012 ª2012Alexa568 for 10 min at 4C to prevent internalization of CXCR4-Venus. The
cells were washed with ice-cold F-12 twice and analyzed with a confocal
scanning laser microscope as described above.
Colocalization of R8-Alexa568 and Tat-Alexa568 with CXCR4 was also
observed using confocal microscopy similar to that with R12-Alexa568.
CXCR4 Internalization Assay
E3-CXCR4 CHO cells were similarly established as the CHO-C4V cells, and
were detached using Versene. Cells (0.4 3 106) were resuspended in F-12
medium containing R12 or SDF-1a (500 ml), incubated at 4C or 37C for
30 min, and washed twice with ice-cold PBS containing 0.5% (w/v) heparin
and PBS. The cells were treated with 100 nM fluorescein-labeled K4 peptide
(FL-K4) (Yano et al., 2008) in F-12 (100 ml) at 4C for 15 min and analyzed using
a FACSCalibur flow cytometer. Ten thousand events were analyzed per
sample (n = 3).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chembiol.2012.09.011.
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